- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - AZ and Luye Pharma enter agreement for Seroquel
AnnouncementREG - AstraZeneca PLC - Director Declaration
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - Circassia Pharma Plc AstraZeneca PLC - Issue of Equity - AstraZeneca
AnnouncementREG - AstraZeneca PLC - AstraZeneca:high level results of the ARCTIC trial
AnnouncementREG - AstraZeneca PLC - FDA approves Tagrisso for 1st-line use in NSCLC
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Directorate Change
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - FDA TO REVIEW MOXETUMOMAB FOR HAIRY CELL LEUKAEMIA
AnnouncementREG - AstraZeneca PLC - AZ AND MSD SUBMIT LYNPARZA FOR BREAST CANCER IN EU
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Lokelma approved in the EU
AnnouncementREG - AstraZeneca PLC - ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Lynparza CHMP for ovarian cancer maintainance <Origin Href="QuoteRef">AZN.L</Origin>
Announcement